Skip to main content

Lumera and MUSC Sign Protein Array Development Pact

NEW YORK, Feb. 6 (GenomeWeb News) - Lumera and the Medical University of South Carolina have signed a co-development agreement, Lumera said today.

 

Under the deal, MUSC researchers will work with Lumera to co-develop a new protein array based on Lumera's NanoCapture HPT technology.

 

In addition, MUSC has committed to buying Lumera's ProteomicProcessor biosensor instrument.

 

Lumera retains the commercial rights to all jointly developed intellectual property, Lumera said.

 

No further details were provided.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.